Biomarkers of lipid peroxidation related to hypertension in aging

Hypertension Research

Volumn 39, Issue 5, 2016, Pages 342-348

  Yavuzer, Hakan ^a   Yavuzer, Serap ^a   Cengiz, Mahir ^a   Erman, Hayriye ^b   Doventas, Alper ^a   Balci, Huriye ^a   Erdincler, Deniz Suna ^a   Uzun, Hafize ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

8 iso prostaglandin F2 ; aging; hexanoyl lysine; lipid peroxidation

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANTIOXIDANT; BIOLOGICAL MARKER; HEXANOYL LYSINE; LIPID HYDROPEROXIDE; LYSINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; 8-EPI-PROSTAGLANDIN F2ALPHA; LIPID PEROXIDE; PROSTAGLANDIN F2 ALPHA;

ADULT; AGED; AGING; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; LIPID PEROXIDATION; MALE; MIDDLE AGED; SENSITIVITY ANALYSIS; ANALOGS AND DERIVATIVES; BLOOD; METABOLISM; NORMAL HUMAN; PHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; CAROTID INTIMA-MEDIA THICKNESS; DINOPROST; FEMALE; HEALTHY VOLUNTEERS; HUMANS; HYPERTENSION; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84966714444     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.156     Document Type: Article

References (39)

1. Saxena R. Arthritis as a disease of ageing and changes in antioxidant status. In: Preedy VR (ed), Aging: Oxidative Stress and Dietary Antioxidants, (1st edn. Academic Press Elsevier Publications: London, 2014, 49-59.
2. Ramana KV, Srivastava S, Singhal SS. Lipid peroxidation products in human health and disease 2014. Oxid Med Cell Longev 2014; 2014: 162414.
3. Sakai K, Kino S, Masuda A, Takeuchi M, Ochi T, Osredkar J, Rejc B, Gersak K, Ramarathnam N, Kato Y. Determination of HEL (Hexanoyl-lysine adduct): a novel biomarker for omega-6 PUFA oxidation. Subcell Biochem 2014; 77: 61-72.
4. Basu S. Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 219-225.
5. Sies H. Total antioxidant capacity: appraisal of a concept. J Nutr 2007; 137: 1493-1495.
6. Kong X, Jia X, Wei Y, Cui M, Wang Z, Tang L, Li W, Zhu Z, Chen P, Xu D. Association between microalbuminuria and subclinical atherosclerosis evaluated by carotid artery intimamedia in elderly patients with normal renal function. BMC Nephrol 2012; 13: 37-39.
7. Xie W, Liu J, Wang W, Wang M, Li Y, Sun J, Liu J, Qi Y, Zhao F, Zhao D. Five-year change in systolic blood pressure is independently associated with carotid atherosclerosis progression: a population-based cohort study. Hypertens Res 2014; 37: 960-965.
8. Reaven PD, Napoli C, Merat S, Witztumc JL. Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 2000; 34:527-537.
9. Seres I, Paragh G, Deschene E, Fulop T Jr, Khalil A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 2004; 39: 59-66.
10. Dincer Y, Sekercioglu N, Pekpak M, Gunes KN, Akcay T. Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease. Ren Fail 2008; 30:1006-1011.
11. Yoo SM, Choi SH, Jung MD, Lim SC, Baek SH. Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats. Hypertens Res 2015; 38: 106-115.
12. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
13. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
14. Benzi IFF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999; 299:15-27.
15. Uzun H, Karter Y, Aydin S, Curgunlu A, Simşek G, Yücel R, Vehiyd S, Ertürk N, Kutlu A, Benian A, Yaldiran A, Oztürk E, Erdine S. Oxidative stress in white coat hypertension; role of paraoxonase. J Hum Hypertens 2004; 18: 523-528.
16. Dominguez LJ, Galioto A, Pineo A, Ferlisi A, Ciaccio M, Putignano E, Belvedere M, Costanza G, Barbagallo M. Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus. J Am Coll Nutr 2010; 29: 1-6.
17. Kedziora-Kornatowska K, Szewczyk-Golec K, Czuczejko J, Pawluk H, van Marke de Lumen K, Kozakiewicz M, Bartosz G, Kedziora J. Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res 2008; 45: 312-317.
18. Sato K, Dohi Y, Kojima M, Miyagawa K, Takase H, Katada E, Suzuki S. Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arzneimittelforschung 2006; 56: 535-540.
19. Armas-Padilla MC, Armas-Hernández MJ, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero J, Carvajal AR, Hernández-Hernández R, Israili ZH, Valasco M. Nitric oxide and malondialdehyde in human hypertension. Am J Ther 2007; 14:172-176.
20. Akila VP, Harishchandra H, D'souza V, D'souza B. Age related changes in lipid peroxidation and antioxidants in elderly people. Indian J Clin Biochem. 2007; 22: 131-134.
21. Ahmad A, Singhal U, Hossain MM, Islam N, Rizvi I. The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension. J Clin Diagn Res 2013; 7: 987-990.
22. Kedziora-Kornatowska K, Czuczejko J, Pawluk H, Kornatowski T, Motyl J, Szadujkis-Szadurski L, Szewczyk-Golec K, Kedziora J. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett 2004; 9: 635-641.
23. Tabak O, Gelisgen R, Erman H, Erdenen F, Muderrisoglu C, Aral H, Uzun H. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med 2011; 34: E163-E171.
24. Kato Y, Mori Y, Makino Y, Morimitsu Y, Hiroi S, Ishikawa T, Osawa T. Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 1999; 274: 20406-20414.
25. Ichikawa D, Kamijo-Ikemori A, Sugaya T, Yasuda T, Hoshino S, Igarashi-Migitaka J, Hirata K, Kimura K. Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury. Hypertension 2012; 60: 973-980.
26. Hozawa A, Ebihara S, Ohmori K, Kuriyama S, Ugajin T, Koizumi Y, Suzuki Y, Matsui T, Arai H, Tsubono Y, Sasaki H, Tsuji I. Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya Project. Hypertens Res 2004; 27: 557-561.
27. de Faria AP, Fontana V, Modolo R, Barbaro NR, Sabbatini AR, Pansani IF, Ferreira-Melo SE, Moreno H. Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. Clin Chim Acta 2014; 433: 179-183.
28. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP. Relationship between oxidative stress and essential hypertension. Hypertens Res 2007; 30: 1159-1167.
29. Wang B, Zhu H, Sun H, Pan J, Yuan Z, Yu R. Plasma 8-isoprostane concentrations in patients with age-related cataracts. Clin Chem 2005; 51: 1541-1544.
30. Ito N, Ohishi M, Yamamoto K, Tatara Y, Shiota A, Hayashi N, Komai N, Yanagitani Y, Rakugi H, Ogihara T. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats. Am J Hypertens 2007; 20: 792-799.
31. Da Cruz AC, Petronilho F, Heluany CC, Vuolo F, Miguel SP, Quevedo J, Romano-Silva MA, Dal-Pizzol F. Oxidative stress and aging: correlation with clinical parameters. Aging Clin Exp Res 2014; 26: 7-12.
32. Okoduwa SI, Umar IA, Ibrahim S, Bello F, Habila N. Age-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetes patients. J Diabetes Metab Disord 2015; 14: 32.
33. Goraca A. Assessment of total antioxidant capacity in human plasma. Folia Med (Plovdiv) 2004; 46: 16-21.
34. Cao G, Russell RM, Lischner N, Prior RL. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr 1998; 128: 2383-2390.
35. Gawron-Skarbek A, Chrzczanowicz J, Kostka J, Nowak D, Drygas W, Jegier A, Kostka T. Cardiovascular risk factors and total serum antioxidant capacity in healthy men and in men with coronary heart disease. Biomed Res Int 2014; 2014: 216964.
36. Iversen PO, Ha L, Blomhoff R, Hauge T, Veierød MB. Baseline oxidative defense and survival after 5-7 years among elderly stroke patients at nutritional risk: Follow-up of a randomized, nutritional intervention trial. Clin Nutr 2015; 34: 775-778.
37. Fusco D, Colloca G, Lo Monaco MR, Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2007; 2: 377-387.
38. Henríquez-Sánchez P, Sánchez-Villegas A, Ruano-Rodríguez C, Gea A, Lamuela-Raventós RM, Estruch R, Salas-Salvadó J, Covas MI, Corella D, Schröder H, Gutiérrez-Bedmar M, Santos-Lozano JM, Pintó X, Arós F, Fiol M, Tresserra-Rimbau A, Ros E, Martínez-González MA, Serra-Majem L. Dietary total antioxidant capacity and mortality in the PREDIMED study. Eur J Nutr (e-pub ahead of print 7 February 2015).
39. Magableh MR, Kemp-Harper BK, Hart JL. Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. Hypertens Res 2015; 38: 13-20.